INS and Hyperinsulinemia: Considering that dexamethasone treatment induces marked hypertriacylglycerolemia together with reduced insulin sensitivity, glucose intolerance, and hyperinsulinemia in adult rats [3–5], we explored the potential of bezafibrate treatment in preventing the elevation of plasma triacylglycerol and other adverse metabolic actions induced by dexamethasone treatment.